November 13 According to Reuters, Indonesian President Joko Widodo said on Friday (13th) that the country expects to launch a large-scale vaccination campaign before the end of this year. A vaccine produced by Sinopharm Group.
According to Reuters, Indonesian President Joko Widodo said on Friday (13th) that in order to combat Coronavirus, the country has sought emergency authorization to carry out mass vaccination activities by the end of this year, and has formulated a plan to distribute vaccines across the country. . If the plan is approved by the Indonesian Food and Drug Administration, it means that the world’s fourth most populous country will become one of the first countries in the world to launch a new coronavirus vaccine.
Joko said, “We expect to start vaccination by the end of this year after a series of tests by the Food and Drug Administration.” At the same time, he emphasized that ensuring the safety of the vaccine is a priority, and health workers, police and the military will be vaccinated first. . “Hopefully this (vaccination campaign) will have a positive economic impact, which is very important to us.”
According to Reuters, Indonesian Maritime Affairs Minister Luhut Binsar Pandjaitan subsequently stated that the government expects that vaccination “is likely to be approved in the first week of December this year, and the vaccination process will begin in two weeks.” The official revealed that the initial stage of mass vaccination will use vaccines produced by China Science and Technology and Sinopharm. This year, these companies will provide 18 million doses of vaccine, of which 15 million doses will be produced by Indonesian state-owned pharmaceutical manufacturer Bio Farma.
According to the report, Indonesia is currently the country with the largest number of new coronavirus infections in Southeast Asia, with about 15,000 deaths and 450,000 infected. Health experts warn that this number may be higher due to the lower detection rate. On the 13th, the country added 5444 new confirmed cases of new coronary pneumonia, the largest increase.